Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:29 AM
Ignite Modification Date:
2025-12-25 @ 3:29 AM
NCT ID:
NCT02471105
Eligibility Criteria:
Inclusion Criteria:
* A patient suffering from ocular hypertension, XFG or POAG and needs treatment in both eyes
* Patient is at least 18 years
* Patient is able and willing to participate in the study for the whole duration of the follow up and is willing to sign the consent form.
Exclusion Criteria:
* Unwilling to sign informed consent;
* Younger than 18 years old;
* Ocular condition that are of safety concern and that can interfere with the study results;
* Visual field defects with an MD value above -15dB on either eye on Humphrey (or the equivalent in Octopus) and/or threatening fixation
* Contact lens wearer;
* Closed/barely open anterior chamber angles or history of acute angle closure on either eye as assessed by gonioscopy;
* Ocular surgery (other than glaucoma surgery) or argon laser trabeculoplasty within the past three months on either eye;
* Glaucoma surgery within the past 6 months on either eye;
* Ocular inflammation/infection occurring within three months prior to pre-trial visit on either eye;
* Concomitant topical ocular medication that can interfere with study medication on either eye;
* Known hypersensitivity to any component of the trial drug solutions;
* Other abnormal condition or symptom preventing the patient from entering the trial, according to the Investigator's judgement;
* Refractive surgery patients at any time;
* Women who are pregnant, are of childbearing potential and are not using adequate contraception or are nursing;
* Inability to adhere to treatment/visit plan;
* Have participated in any other Interventional clinical trial (i.e., requiring informed consent) involving an investigational drug within one month prior to pre-trial visit.
* History of COPD, asthma or heart failure
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02471105
Study Brief:
Protocol Section:
NCT02471105